Supernus Pharmaceuticals, Inc. (SUPN)
45.11
-0.74
(-1.61%)
USD |
NASDAQ |
Aug 24, 16:00
44.01
-1.10
(-2.44%)
After-Hours: 05:12
Supernus Pharmaceuticals Market Cap : 2.624B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.624B |
| August 21, 2026 | 2.667B |
| August 20, 2026 | 2.760B |
| August 19, 2026 | 2.823B |
| August 18, 2026 | 2.852B |
| August 17, 2026 | 2.808B |
| August 14, 2026 | 2.808B |
| August 13, 2026 | 2.742B |
| August 12, 2026 | 2.784B |
| August 11, 2026 | 2.727B |
| August 10, 2026 | 2.738B |
| August 07, 2026 | 2.771B |
| August 06, 2026 | 2.720B |
| August 05, 2026 | 2.728B |
| August 04, 2026 | 2.516B |
| August 03, 2026 | 2.676B |
| July 31, 2026 | 2.596B |
| July 30, 2026 | 2.653B |
| July 29, 2026 | 2.709B |
| July 28, 2026 | 2.770B |
| July 27, 2026 | 2.727B |
| July 24, 2026 | 2.681B |
| July 23, 2026 | 2.739B |
| July 22, 2026 | 2.724B |
| July 21, 2026 | 2.778B |
| Date | Value |
|---|---|
| July 20, 2026 | 2.752B |
| July 17, 2026 | 2.788B |
| July 16, 2026 | 2.798B |
| July 15, 2026 | 2.770B |
| July 14, 2026 | 2.708B |
| July 13, 2026 | 2.748B |
| July 10, 2026 | 2.813B |
| July 09, 2026 | 2.829B |
| July 08, 2026 | 2.928B |
| July 07, 2026 | 2.782B |
| July 06, 2026 | 2.742B |
| July 02, 2026 | 2.789B |
| July 01, 2026 | 2.752B |
| June 30, 2026 | 2.699B |
| June 29, 2026 | 2.716B |
| June 26, 2026 | 2.719B |
| June 25, 2026 | 2.597B |
| June 24, 2026 | 2.620B |
| June 23, 2026 | 2.582B |
| June 22, 2026 | 2.582B |
| June 18, 2026 | 2.576B |
| June 17, 2026 | 2.529B |
| June 16, 2026 | 2.529B |
| June 15, 2026 | 2.546B |
| June 12, 2026 | 2.578B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Indivior Pharmaceuticals, Inc. | 4.269B |
| Pfizer Inc. | 159.40B |
| Amphastar Pharmaceuticals, Inc. | 915.29M |
| Collegium Pharmaceutical, Inc. | 888.83M |
| Bristol Myers Squibb Co. | 137.45B |
Market Cap Related Metrics
| PS Ratio | 3.118 |
| Price to Book Value | 2.544 |
| Price to Free Cash Flow | 137.83 |
| Price | 45.11 |
| Earnings Yield | -4.24% |